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INTRODUCTION:  Sarcomatoid  carcinoma  (SCA)  of jejunum  is  an extremely  rare  condition.  To  our  knowl-
edge,  only  17 cases  have  been  reported  in  the  literature.
PRESENTATION:  We  introduced  an  additional  case  of the  sarcomatoid  carcinoma  of jejunum  in a  62-
year-old  Chinese  male  who  presented  with  epigastric  pain  for 3  weeks.  Multiple  tumors  originated
in  the jejunum  and  metastases  to mesentery  lymph  nodes  and  distal  stomach  were  found  during  the
laparotomy.  The  patient  underwent  palliative  resection  of  the  tumors.  He  died  11 days  after  the  operation.
DISCUSSION:  Sarcomatoid  carcinoma  (SCA)  of  jejunum  is  an extremely  poor  prognostic  tumor  in human
being.  The  diagnosis  of SCA was  based  on  pathological  observations  and  immunohistochemical  staining.astric metastases There  is  no ofﬁcial  treatment  guideline  for SCA, but wide  excision  including  the  tumor  is the  main  goal
of treatment.
CONCLUSION:  This  is  the  ﬁrst  case  of sarcomatoid  carcinoma  of  jejunum  with  gastric  metastases  being
reported  and also  the  shortest  survival  period  after  the  operation.  Surgery  is  the  cornerstones  of  treatment
but the ideal  means  is  still  unknown  due  to the  short  survival  and  inadequate  reports.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Sarcomatoid carcinoma (SCA) of jejunum is an extremely rare
iphasic tumor characterized by a combination of malignant
pithelial and mesenchymal cells [1–3]. Carcinosarcoma, pleomor-
hic carcinoma and anaplastic giant-cell carcinoma have been
reviously used to describe this kind of tumor. Nowadays, SCA
ecame the most accepted term used in diagnostic surgical reports
2,3]. To our knowledge, only 17 cases of primary SCA of the
ejunum have been reported in the literature to date [4]. The tumor
s known to be more malignant than other small intestine cancers
5], and patients with this disease have a signiﬁcantly worse prog-
osis due to the tumor’s metastatic nature and aggressive clinical
ourse. We  report an additional case (18th case) of primary SCA of
he jejunum in a 60-year-old Chinese male. He received laparotomy
nd palliative resection of the tumors. However, he died 11 days
fter the operation.
. Case presentationA 60-year-old Chinese male with no medical morbidity in the
ast presented with epigastric pain for three weeks. He was  a
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heavy smoker with two  packs a day, quitted for two months; and
alcohol drinking with two  bottles every day for several decades,
quitted for several months. Abdominal fullness, general malaise
and poor digestion took place in the meantime. He visited sev-
eral local clinics vainly and the symptoms got worse. Our upper
gastrointestinal endoscopy displayed a protruding nodular mass
in a 2 cm deep dirty based gastric ulcer at lesser curvature side
of low body of stomach. Malignancy or gastrointestinal stromal
tumor (GIST) was  suspected and biopsy was  performed. Moreover,
colonoscopy showed a 1.5 cm pedunculated polyp at 40 cm from
anal verge and polypectomy was  executed. Laboratory data includ-
ing blood routine, biochemistry and tumor markers were within
normal limits except mild anemia (hemoglobin (Hb) 10.4 g/dL) and
hypoalbuminemia (2.4 g/dL).
Blood loss was  noticed after one week of his admission (Hb:
7.8 g/dL). Chest X-ray showed a right upper lobe soft tissue opacity
and further computed tomography detected a 5.3 × 5 × 6.7 cm lung
cancer over right upper lobe with adrenal metastases, cT2bN0M1b;
mucosal wall thickening at lesser curvature of lower body of stom-
ach; ileus of bowel loops; a 5.72 × 7.54 × 7.03 cm well deﬁned
heterogeneous cystic mass with peripheral contrast enhancement
in the left adrenal gland; and multiple gall stones. The pathology
reports of stomach biopsy and colon polypectomy showed adeno-
carcinoma and tubulovillous adenoma respectively. Gastric cancer
and lung cancer were impressed. Surgical treatment for abdomen
was ﬁrst considered in priority before treatment for lung condition.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Multiple tumor masses in the jejunum (yellow arrows).
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Hig. 2. 3 cm Ulcerative tumor in the lesser curvature side of distal stomach at angu-
aris (white arrow).
The operation ﬁndings during the exploratory laparotomy
ncluded: a 3 cm ulcerative tumor in the lesser curvature side of
istal stomach at angularis (Fig. 1); multiple tumor masses in the
ejunum (Fig. 2), lymph nodes enlargement in the jejunal mesen-
ery and at the 4th portion of duodenal mesentery, and multiple gall
tones in the gall bladder. We  performed hemigastrectomy, exci-
ion of a long segment of jejunum, gastrojejunostomy and open
holecystectomy. The initial post-operative course was smooth.
owever, gastroparesis occurred and parenteral nutrition support
Fig. 3. Positive immunohistological stPEN  ACCESS
ry Case Reports 28 (2016) 161–164
was given. Sudden onset of apnea and cardiac arrest occurred and
the patient had no response to our resuscitation effort. Finally the
patient died 11 days after the operation.
The pathology report showed poorly differentiated sarcoma-
toid carcinoma of jejunum (5 in submucosa and one inﬁltrated to
mesointestine, largest 5 cm in circumference), one of the lymph
node contained tumor cells, and metastatic to stomach. The
main tumors in jejunum invaded to the visceral peritoneum with
discontinuous extramural extension of tumor deposits, present
of lymphovascular invasion and macroscopic tumor perforation.
The immunohistochemistry showed CK(+), vimentin(+), P63(−),
S100(−), CD117(−), CD34(−),  SMA(−), CD30(−), EMA(−), Bc12(−),
CD21(−), CD1a(−),  CK7(−), CD20(−), WT-1(−)  and calretinin(−)
(Fig. 3). Our ﬁnal diagnosis was jejunual sarcomatoid carci-
noma with stomach, jejunum, mesenteric lymph nodes metastasis,
pT(m)3N1M1, stage IV, and right upper lobe lung cancer with
adrenal metastases, cT2bN0M1b.
3. Discussion
Adenocarcinoma, neuroendocrine tumors, sarcomas and lym-
phomas are the four most common malignant tumors arising in
the small intestine [6]. Primary SCA of small bowel is rare and most
often it occurred in ileum, followed by jejunum and duodenum
[2]. To our knowledge, there were 17 cases of jejunal SCA reported
in the literature to date (Table 1) but the real incidence rate may
be underestimated. These tumors normally affect middle-aged to
elderly patients with a mean age at presentation of 57 years (range,
35–85 years). Reid-Nicholson et al. reported that SCA of the small
intestine is more prevalent in male patients, with a male:female
ratio of 1.5:1.0 [2], which is different from the recent report from
Zhang B et al. showing no signiﬁcant difference with a male:female
ratio of 0.89:1.0 [4]. Most SCAs of the jejunum are typically single
tumors, and only 2 patients exhibited multifocal primary tumors
[7]. Most of the reported cases presented with metastases (13/18)
and most cases died rapidly after the diagnosis. Our case is an addi-
tional (the 3rd case) multifocal tumor of SCA in jejunum, and also
the ﬁrst case with stomach metastases. The late presentation and
diagnosis can explain the poor prognosis of our patient and we
felt distressed with his ultrashort survival since he died 11 days
after surgery, which is the shortest one presented in the litera-
ture. However, we guess there is a portion of patients died before
any deﬁnite diagnosis can be made because of its rapid progression
and metastases, which leads to under presentation of this kind of
cancer.The risk factors of SCA are unknown, but in certain publica-
tions, a correlation with long-standing regional enteritis has been
referenced [8,9]. Zhang et al. [4] listed the complete clinical and
pathological data (Table 2) in his report earlier. Anemia was the
ain for (A) CK and (B) vimentin.
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Table  1
Review of published cases of sarcomatoid carcinoma (SCA) of the jejunum. (Modiﬁed from Zhang et al. [4]).
Age, years Diagnostic Size, Immunohistochemistry Presence of Death after
Source year /gender term cm Morphology Vimentin CK EMA  CEA metastases diagnosis, mo
Robbey-Cafferty et al. [5] 38/F Anasplastic and SCA 16 Endophytic N/A + N/A + Yes 8
48/F  Anasplastic and SCA 6 Endophytic N/A + N/A + Yes 29
65/M  Anasplastic and SCA 5 Endophytic N/A + N/A + Yes 5
35/F  Anasplastic and SCA 7.5 Endophytic N/A - N/A - Yes 36
Bak  and Teglbjaery [7] 52/F Pleomorphic CA 8 N/A + + + N/A Yes 7
56/M  Pleomorphic CA 8 N/A + + + N/A Yes 8
Lam  et al. [10] 76/F SCA 8 N/A + + + N/A No 2
Tsukadaira et al. [11] 56/M SCA 9.2 Endophytic + + + - Yes 3
Reid-Nicholson et al. [2] 55/M SCA 7.5 Polypoid + + + - Yes 11
Moriwaki and Sugiyama [12] 55/M SCA N/A N/A N/A + + N/A N/A 9.4
Yucel  et al. [13] 51/F SCA 8 Polypoid + + N/A N/A Yes 1.9
Pata  et al. [14] 85/F SCA 3 Polypoid N/A + N/A N/A No 3
Han  et al. [15] 2013 70/F SCA N/A N/A +++ + - N/A No N/A
Kang  et al. [16] 78/M SCA 5 Endophytic +++ + N/A N/A N/A N/A
Alfonso Puentes et al. [17] 56/F SCA 10 N/A + + + N/A Yes 6
Lee  et al. [3] 2015 67/M SCA 10 N/A +++ + N/A - Yes 1.4
Zhang et al. [4] 62/M SCA 12 Endophytic +++ + + - Yes 1
Present case, 2016 60/M SCA 3.6 En
F, female; M,  male; CK, cytokeratin; EMA, epithelial membrane antigen; CEA, carcinoemb
Table  2
Summary of clinicopathological characteristics of patients with sarcomatoid carci-
noma (SCA) of the jejunum. Modiﬁed from Zhang et al. [4].
Characteristics No. of patients (%)
Clinical presentation (n = 14)
Anemia 8 (57.1)
Abdominal pain 6 (42.9)
Abdominal mass 4 (28.6)
Gastrointestinal bleeding 4 (28.6)
Weight loss 4 (28.6)
Fatigue 4 (28.6)
Small intestinal obstruction 2 (14.3)
Shortness of breath on effort 2 (14.3)
Palpitations 2 (14.3)
Subphrenic free air 2 (14.3)
Vomiting 2 (14.3)
Fever 1 (7.1)
Diarrhea 1 (7.1)
Dyspepsia 1 (7.1)
Anorexia 1 (7.1)
Greatest dimension of tumor, cm (n = 12)
<5 1 (8.3)
5–10 9 (75.0)
>10 2 (16.7)
Depth of invasion (n = 12)
Muscularis propria 1 (8.3)
Subserosal layer 2 (16.7)
Full thickness of the wall 9 (75.0)
Regional lymph nodes (n = 10)
Metastasis 9 (90.0)
No metastasis 1 (10.0)
Distant metastasis (n = 12)
Lung 6 (50.0)
Liver 3 (25.0)
Para-aortic lymph nodes 2 (16.7)
Cervical lymph nodes 2 (16.7)
Axillary lymph nodes 1 (8.3)
Pelvic bone 1 (8.3)
Brain 1 (8.3)
Lymphovascular or perineural invasion (n = 11)
Yes  6 (54.5)
No 5 (45.5)
Extension into adjacent organs (n = 6)
Small bowel loops 3 (50.0)
Colon 2 (33.3)
Mesentery 2 (33.3)
Omentum 2 (33.3)
Ovary 1 (16.7)dophytic + + - N/A Yes 0.36
ryonic antigen; mo,  month; N/A, not applicable; CA, carcinoma.
most common symptom, followed by abdominal pain, palpable
abdominal mass, gastrointestinal bleeding, weight loss and fatigue.
Two patients presented with cancerous bleeding that required
emergency laparotomy [11], and another 2 patients experienced
tumor perforation with subphrenic free air and acute peritonitis
[13,15]. Additionally, shortness of breath on effort, palpitations,
vomiting, fever, nausea, diarrhea, dyspepsia and anorexia may
also be the initial symptoms of patients with primary SCA of the
jejunum. The remarkably non-speciﬁc clinical manifestations of
jejunal SCA make early diagnosis difﬁcult.
The diagnosis of SCA was  based on pathological observations.
They are typically endophytic or polypoid masses with central
ulceration. Most tumors involve the entire wall of the jejunum with
regional lymph node metastasis, and directly invaded neighbor-
ing structures. Moreover, prominent lymphovascular or perineural
invasion was  found in 54.5% of the patients. The most common
metastatic locations are the lung, distant lymph nodes and liver,
while the brain and pelvic bones may  also be involved. All the 18
cases reported (including our patient) succumbed to the disease,
and more than 80% had metastatic or recurrent disease at death,
indicating the aggressive and metastatic nature of this tumor. The
overall survival time after diagnosis is only 8.25 months (range,
0–36 months, including the present case).
Immunohistochemical staining also contributes to the diag-
nosis. SCA may  exhibit a monophasic or biphasic pattern [5]. A
predominance of the mesenchymal-like component, with minimal
to absent epithelioid areas, characterizes the typical monophasic
pattern, whereas biphasic tumors display a mixture of epithelial-
like and mesenchymal-like cells. In the majority of SCA, epithelial-
and mesenchymal-like components exhibit positivity for EMA. In
addition, ∼90% of intestinal sarcomatoid carcinomas are positive
for vimentin. Certain cases may  also exhibit focal positivity for neu-
roendocrine and neuron-speciﬁc markers [2]. Han et al. reported a
suggestion of relatively favorable prognosis with the presentation
of low positivity for Ki-67 in the tumor [15]. Our immuno-
histochemical staining results revealed positive expression of
vimentin and CK, indicating that the sarcomatous component dis-
played epithelial and mesenchymal differentiation and SCA was
impressed.
There is no ofﬁcial treatment guideline for SCA, but wide exci-
sion including the tumor is the main goal of treatment. There
are cases in which adjuvant chemotherapy using 5-FU and/or cis-
platin and radiotherapy were administered, but no report identiﬁed
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mprovements in survival. Recent clinical trials using monoclonal
ntibodies targeting immune checkpoint programmed death pro-
ein I (PD-1) and its ligand, PD-L1, reported promising antitumor
ctivity in several malignancies. Upregulated PD-L1 expression on
umor cells is considered to mediate immune evasion via activation
f the PD-1/PD-L1 pathway and suppression of effector immune
esponses [18]. B Zhang et al. discovered a distinct expression of
he PD-L1 protein in primary SCA of the jejunum [4], indicating the
otential of PD-L1–targeted immunotherapy for the treatment of
his type of cancer.
. Conclusion
Sarcomatoid carcinoma of jejunum is an aggressive neoplasm
ith metastatic nature and extremely poor prognosis. Surgery is
he cornerstones of treatment but the ideal means is still unknown
ue to the short survival and inadequate reports. Early detection
ay  improve the prognosis.
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